Technologies we are applying
We are at the cutting edge of ophthalmology, gene therapy and drug development in our search for solutions for patients with neurodegenerative diseases. Our products combine a gene therapy-based approach with our core proprietary technology platforms of mitochondrial targeting sequence, or MTS, and optogenetics.
